Alpha Tau Medical Ltd logo

Alpha Tau Medical Ltd

DRTS | NASDAQ
Chart Builder DCF Calculator
$15.09
-$0.41 (-2.65%)
Sep 22, 2026, 1:55 PM ET · Market open
TTM
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a 1.07M 1.07M 1.59M 1.59M 1.49M 1.49M 979K 1.21M 1.01M 1.01M 1.01M 776K n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a -1.07M -1.07M -1.59M -1.59M -1.49M -1.49M -979K -1.21M -1.01M -1.01M -1.01M -776K n/a n/a n/a
Operating Income
-50.43M -46.29M -42.29M -39.96M -37.52M -36.93M -36.04M -35.71M -36.35M -35.46M -35.68M -33.72M -32.16M -32M -32.14M -28.09M -24.37M -19.84M -13.79M -12.56M -11.64M -10.07M
Interest Income
n/a 944K 1.66M 2.46M 3.65M 4.57M 4.3M 4.26M 3.07M 1.21M 763K 7.99K 12.73K 12.73K 12.73K 204.12K 199.38K 199.38K 199.38K n/a n/a 164.5K
Pretax Income
-92.4M -56.86M -42.51M -39.81M -35.04M -32.36M -31.74M -29.63M -27.65M -28.96M -29.14M -25.18M -22.84M -16.17M -33.74M -34.14M -36.33M -41.31M -27.26M -25.88M -23.5M -18.48M
Net Income
-92.57M -56.88M -42.63M -39.97M -35.21M -32.46M -31.75M -29.64M -27.63M -28.95M -29.16M -25.19M -22.9M -16.21M -33.76M -34.15M -36.32M -41.3M -27.27M -25.91M -23.54M -18.57M
Selling & General & Admin
11.66M 10.42M 10.22M 9.94M 9.63M 9.18M 9.02M 8.73M 8.87M 8.89M 9.26M 9.41M 9.69M 10.04M 11.25M 9.36M 7.43M 5.34M 2.34M 2.1M 1.98M 1.87M
Research & Development
38.77M 35.87M 32.07M 30.02M 27.89M 27.74M 27.02M 26.98M 27.48M 26.57M 26.42M 24.31M 22.47M 21.96M 20.89M 18.74M 16.94M 14.49M 11.45M 10.9M 10.54M 9.08M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a -1.07M -1.07M -1.07M -1.07M n/a n/a n/a n/a n/a n/a n/a n/a -4.69M -9.39M -14.08M
Operating Expenses
50.43M 46.29M 42.29M 39.96M 37.52M 36.93M 36.04M 34.64M 35.27M 34.39M 34.61M 33.72M 32.16M 32M 32.14M 28.09M 24.37M 19.84M 13.79M 12.4M 11.33M 9.96M
Interest Expense
43.78M 11.98M 2.34M 2.34M n/a n/a n/a n/a n/a n/a n/a 7.97M 12.71M 18.73M 35.69M 27.72M 24.15M 21.62M 13.62M 13.62M 12.45M 8.97M
Selling & Marketing Expenses
1.49M 1.64M 1.86M 2.1M 2.13M 2.28M 2.35M 2.11M 2.14M 2.06M 1.92M 1.87M 1.57M 1.17M 974K 703K 557K 523K 482K 428.5K 399K 383.5K
Cost & Expenses
50.43M 46.29M 42.29M 39.96M 37.52M 36.93M 36.04M 35.71M 36.35M 35.46M 35.68M 33.72M 32.16M 32M 32.14M 28.09M 24.37M 19.84M 13.79M 12.4M 11.33M 9.96M
Income Tax Expense
175K 11K 121K 158K 166K 104K 6K 12K -27K -4K 16K 11K 59K 39K 20K 3K -11K -2K 7K 27.5K 39K 96.5K
Shares Outstanding (Basic)
90.95M 89.71M 85.67M 83.75M 80.35M 70.45M 70.09M 69.9M 69.87M 69.71M 69.67M 69.47M 69.32M 69.21M 69.11M 68.8M 68.43M 47.5M 47.5M 67.62M 67.62M 67.62M
Shares Outstanding (Diluted)
90.95M 89.71M 85.67M 85.26M 80.35M 70.45M 70.09M 69.9M 69.87M 69.71M 69.67M 69.47M 69.32M 69.21M 69.11M 68.8M 68.43M 47.5M 47.5M 67.62M 67.62M 67.62M
EPS (Basic)
-1.04 -0.67 -0.53 -0.53 -0.49 -0.47 -0.46 -0.43 -0.40 -0.42 -0.43 -0.37 -0.34 -0.24 -0.66 -0.69 -0.72 -0.79 -0.42 -0.40 -0.40 -0.34
EPS (Diluted)
-1.04 -0.67 -0.53 -0.53 -0.49 -0.47 -0.46 -0.43 -0.40 -0.42 -0.43 -0.37 -0.34 -0.24 -0.66 -0.69 -0.72 -0.79 -0.42 -0.40 -0.40 -0.34
EBITDA
-49.54M -44.93M -40.93M -35.08M -31.9M -31.5M -30.35M -33.82M -34.48M -33.86M -34.1M -32.24M -30.67M -30.29M -30.44M -26.6M -22.93M -18.45M -12.47M -11.99M -11.24M -9.84M
EBIT
-50.77M -46.16M -42.16M -35.36M -32.45M -32.33M -31.44M -35.71M -36.35M -35.96M -36.18M -34.22M -32.65M -32M -32.14M -28.09M -24.37M -19.84M -13.79M -12.56M -11.64M -10.07M
Depreciation & Amortization
1.51M 1.77M 2.05M 1.09M 1.09M 1.1M 1.09M 1.89M 1.87M 2.1M 2.08M 1.98M 1.98M 1.71M 1.7M 1.5M 1.44M 1.39M 1.32M 566K 401K 231K

© 2026 bestshares.com. All rights reserved.